SonoSite Receives FDA Clearance

Bothell, WA-based ultrasound company SonoSite (NASDAQ: SONO) has received FDA clearance for its LumenVu catheter guidance system, the company said yesterday. The technology, designed to aid in the placement of peripherally inserted central catheters (PICC), uses a combination of near-infrared and a fiber optic stylet, replacing a traditional guide wire, and allowing real-time tracking and visualization of a catheter tip as it advances through the vein. There were an estimated 2.5 million PICC lines placements performed in the U.S. in 2008, and although very common, a recent University of Pennsylvania Medical Center study found that only 70 percent of these lines are succesfully placed on the first attempt. The company is also working on a new ultrasound device that will allow physicians to take an up-close look at arteries, and possibly prevent cardiovascular issues

Trending on Xconomy

By posting a comment, you agree to our terms and conditions.

One response to “SonoSite Receives FDA Clearance”

  1. It is a good enhancement in medical technology by SonoSite. Their now project on ultrasound device to closely look at arteries will bring a revolution in cardiac treatment. I appreciate their great efforts.